Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.

Author: ArmstrongApril W, ArmstrongEhrin J, BrezinskiElizabeth A, FollansbeeMatthew R

Paper Details 
Original Abstract of the Article :
BACKGROUND: Whether systemic treatments for psoriasis or psoriatic arthritis affect cardiovascular comorbidities is a clinically significant question. OBJECTIVE: To examine the effects of biologic agents and other Disease-Modifying Antirheumatic Drugs (DMARDs) used to treat psoriasis and psoriatic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2174/138161282004140213123505

データ提供:米国国立医学図書館(NLM)

Cardiovascular Health in Psoriasis and Psoriatic Arthritis: Navigating a Complex Terrain

Psoriasis and psoriatic arthritis are conditions that can be as unpredictable as a desert sandstorm. The impact of medications used to treat these conditions on cardiovascular health is a complex and crucial question. This systematic review, a comprehensive exploration of existing research, delves into the effects of various medications, including biologics and other disease-modifying antirheumatic drugs (DMARDs), on cardiovascular outcomes in patients with psoriasis and psoriatic arthritis. The review highlights the need for further research to understand the long-term cardiovascular implications of these medications.

A Complex Landscape Requires Further Exploration

The research suggests that while some medications may have a positive impact on cardiovascular health, others may require careful monitoring. It’s like navigating a desert landscape; some paths lead to lush oases, while others are fraught with danger. The findings emphasize the need for ongoing research to ensure the best possible outcomes for patients, especially regarding the long-term effects of biologics on cardiovascular health.

Navigating the Desert of Psoriasis and Psoriatic Arthritis: A Focus on Cardiovascular Health

This review highlights the importance of understanding the potential cardiovascular implications of medications used to treat psoriasis and psoriatic arthritis. It is crucial to have open and honest conversations with your doctor about your medical history and any potential risks associated with your treatment. This knowledge will help you navigate the complex terrain of these conditions and make informed decisions about your health.

Dr. Camel's Conclusion

This research reminds us that the desert of psoriasis and psoriatic arthritis is a complex and challenging landscape, and navigating its terrain requires careful consideration of all aspects of health, including cardiovascular well-being.

Date :
  1. Date Completed 2014-11-03
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

23565631

DOI: Digital Object Identifier

10.2174/138161282004140213123505

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.